Overview
SCNI market data
Price History
SCNI price chart · 1M
- O
- 2.80
- H
- 3.00
- L
- 2.80
- C
- 2.84
- Vol
- 563.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.80
- Previous Close
- $2.82
- Day High
- $3.00
- Day Low
- $2.80
- 52 Week High
- $7.30
- 52 Week Low
- $2.21
- 7 Day Return
- +1.57%
- 30 Day Return
- +23.48%
- 90 Day Return
- -36.87%
- 1 Year Return
- -57.49%
- Daily Notional Volume
- $1.6K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.00 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.17 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -344.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.15 – $16.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.6M · P/B 0.08 · P/S 0.64.
Company News
Scinai Immunotherapeutics H1 Net Income $1.6M Vs Loss $4.1M Prior Year; Revenues $949K Up From $773K YoY; Continues To Pursue ~$5M In CDMO Revenues For 2026Benzinga · Aug 24, 2026, 1:28 PM